Afeyan Noubar's Form 4 filing
Sana Biotechnology, Inc. (SANA) · filed Jun 8, 2023
- Accession no.
- 0000899243-23-014953
- Filed
- Jun 8, 2023, 7:00 PM ET
- Trade date
- Jun 6-7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.53M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Afeyan NoubarCIK 0001222012 | 10% Owner |
| Flagship Ventures Fund V, L.P.CIK 0001627639 | 10% Owner |
| Flagship Ventures Fund V General Partner LLCCIK 0001724575 | 10% Owner |
| Flagship V VentureLabs Rx Fund, L.P.CIK 0001724939 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | Common Stock | SSaleDisposed | −181,461 | $6.31 | −$1,144,311.21 | 10,920,533 | Indirect | |
| Jun 6, 2023 | Common Stock | SSaleDisposed | −22,297 | $6.31 | −$140,607.11 | 1,403,037 | Indirect | |
| Jun 7, 2023 | Common Stock | SSaleDisposed | −177,240 | $6.24 | −$1,105,924.43 | 10,743,293 | Indirect | |
| Jun 7, 2023 | Common Stock | SSaleDisposed | −22,760 | $6.24 | −$142,015.57 | 1,380,277 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.